Skip to main content

Sanofi-Aventis S.A. ADR(SNY-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Sanofi-Aventis S.A. ADR

46 AVENUE DE LA GRANDE ARMEE
PARIS I0 75017 FRA
P: 33-1-53-77-44-00
http://www.sanofi.com

Profile

Sanofi-Aventis manufactures & markets prescription drugs across countries. It focuses on major therapeutic areas such as multiple sclerosis, cardiovascular, immunology, neurology, oncology, rare blood disorders & diabetes, etc. By taking Genzyme Corporation as a subsidiary, it added products like Cerezyme, Myozyme/Lumizyme & Fabrazyme to its portfolio. Sanofi has become a major player in the CHC sector. It acquired many companies i.e. Ablynx & Bioverativ, Synthorx & Principia & Translate Bio and Kadmon. It has collaborated with companies like Regeneron among others. It develops and markets Dupixent, Kevzara & Libtayo in collaboration with Regeneron. Sanofi, along with Regeneron, is now solely responsible for Praluent marketing in & outside the U.S. Sanofi operates through 3 Global Business Units: Specialty Care (neurology & immunology, rare diseases, rare blood disorders & oncology), Vaccines & General Medicines (diabetes, cardiovascular & established products) and Consumer Healthcare, a standalone unit.

Key Executives

NameTitle
Francois-Xavier RogerCFO/Executive VP
Olivier CharmeilCEO/Executive VP, Divisional
Natalie BickfordExecutive VP/Other Executive Officer
Thomas TriompheExecutive VP, Divisional
Brendan O'CallaghanExecutive VP, Divisional
Roy PapatheodorouExecutive VP/General Counsel
Madeleine RoachExecutive VP, Divisional
Emmanuel FrenehardExecutive VP/Other Executive Officer
Houman AshrafianExecutive VP/Other Corporate Officer
Audrey DuvalExecutive VP, Divisional
Manuela BuxoExecutive VP, Divisional

More from The Globe

Analysts’ forecast returns, recommendations and yields for all stocks in the S&P/TSX SmallCap Index
The S&P TSX composite index screen at the TMX Market Centre in Toronto is photographed on Friday, November 11, 2022.
Small caps to watch: Aecon, Maple Leaf Foods, Tecsys and more
Packages of Maple Leaf Foods chicken breasts are shown on a shelf at a grocery store in Oakville, Ont., Friday, Jan.6, 2023.
Thursday’s analyst upgrades and downgrades
A pumpjack operates at the Vermilion Energy site in Trigueres, France, June 14, 2024.
Wednesday’s analyst upgrades and downgrades
A Pet Valu store is pictured in Ottawa, Tuesday, Sept. 13, 2022.
number cruncher
Seven Canadian oil producers set to benefit from rising prices
For Number Cruncher column in Globe Investor/ROB only.
Bullish on Mullen Group Ltd.
Monica Rizk
Top non-resource stocks on the TSX with strong insider signals
Ted Dixon
Berkshire Hathaway shares have largest slide since Buffett’s resignation
FILE PHOTO: A screen displays the trading information for Berkshire Hathaway inc. as traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October 22, 2025. REUTERS/Brendan McDermid/File Photo

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.